Clinical Trial Update: Prialt (Ziconotide) In Severe Chronic Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ziconotide (Prialt) for severe chronic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Prialt (ziconotide)

Snippet

Sponsor: Elan Pharmaceuticals | Conditions: Pain | Phase 3 | Status: COMPLETED